Thomas Gallagher Speaks On How Understanding Sarbanes-Oxley, Industry Compliance Guidance And The Changing Organizational Sentencing Guidelines Affect Government Investigations Of Pharmaceutical Companies At Institute for International Research Conference
10/19/2005 5:11:12 PM
The Sarbanes-Oxley Act of 2002 was passed in the wake of Enron and other corporate accounting scandals to prevent ethics scandals and other governance problems from recurring and to rebuild public trust in corporate business and reporting practices. The new Act is dramatically altering the legal and compliance landscape for the pharmaceutical industry.
comments powered by